Disentangling post-vaccination symptoms from early COVID-19
Research paper
[키워드] 1:1
Asymptomatic
AUC, area under the curve
bMEM, Bayesian mixed-effect model
BMI, Body mass index
BNT162b2
ChAdOx1 nCoV-19
chronic
CI, Confidence interval
clinical information
Community
Comorbidities
conducted
cough
Council
COVID
COVID-19
COVID-19 detection
COVID-19, Coronavirus disease 2019
criteria
Critical
CSS
CSS, COVID Symptoms Study
demographic
Department
DI, Data invalid
Early detection
Engineering
fatigue
Fever
finding
foundation
funding
headache
heart
identifying
individual
infection control
injection
IQR, inter quartile range
KCL, King's College London
LFAT, Lateral flow antigen test
Local
LR, Logistic Regression
Medical Research Council
Mobile technology
MOST
myalgia
NHS UK, National Health Service of the United Kingdom
O-AZ, Oxford-AstraZeneca adenovirus-vectored vaccine
overlap
Oxford-AstraZeneca adenovirus-vectored vaccine
participant
Participants
PB, Pfizer-BoiNTech mRNA vaccine
Pfizer-BioNTech mRNA vaccine
positive
post-vaccination symptom
presenting
Prevent
profile
prospective observational study
public health
reduce
reported symptom
RF, Random forest
ROC, Receiver operating curve
rtPCR, Reverse transcription polymerase chain reaction
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 test
SARS-CoV-2, Severe acute respiratory syndrome-related coronavirus-2
Science
Self-reported symptoms
sensitivity
Seven
severe acute respiratory syndrome‐related coronavirus 2 (SARS-CoV-2)
severe acute respiratory syndrome‐related coronavirus 2 (SARS-CoV-2)
Side-effect
Side-effects
Spread
Symptom
Symptoms
systemic symptom
tested
UK, United Kingdom of Great Britain and Nothern Ireland
vaccination
were recorded
with COVID-19
[DOI] 10.1016/j.eclinm.2021.101212 PMC 바로가기 [Article Type] Research paper
[DOI] 10.1016/j.eclinm.2021.101212 PMC 바로가기 [Article Type] Research paper